Synthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells.

TitleSynthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells.
Publication TypeJournal Article
Year of Publication2016
AuthorsReedy JL, Hedlund DK, Gabr MT, Henning GM, F Pigge C, Schultz MK
JournalBioconjug Chem
Volume27
Issue10
Pagination2424-2430
Date Published2016 Oct 19
ISSN1520-4812
KeywordsAdenosine Triphosphate, Antineoplastic Agents, Cell Line, Tumor, Cell Survival, Chemistry Techniques, Synthetic, Drug Screening Assays, Antitumor, Fibroblasts, Humans, Melanoma, Membrane Potential, Mitochondrial, Microscopy, Confocal, Microscopy, Fluorescence, Mitochondria, Pyridinium Compounds
Abstract

Metastatic melanoma is the most aggressive and lethal form of skin cancer. Emerging evidence suggests that differences in melanoma metabolism relative to nonmalignant cells represent potential targets for improved therapy for melanoma. Specifically, melanoma cells exhibit increased mitochondrial electron transport chain (ETC) activity and concomitant hyperpolarized mitochondrial membrane potential relative to nonmalignant cells. We have synthesized several new fluorescent lipophilic vinylpyridinium cations built from tetraarylethylene scaffolds that target mitochondria via attraction to the hyperpolarized mitochondrial membrane potential. Mitochondria-specific accumulation in melanoma cells relative to normal human fibroblasts was demonstrated using confocal fluorescence microscopy and resulted in the disruption of oxidative metabolism leading to melanoma specific cell death in vitro. Thus, the pyridinium tetraarylethylene platform represents a promising new mitochondrial-targeted delivery vehicle with potential imaging and therapeutic properties.

DOI10.1021/acs.bioconjchem.6b00394
Alternate JournalBioconjug Chem
PubMed ID27643916
PubMed Central IDPMC5278540
Grant ListT35 HL007485 / HL / NHLBI NIH HHS / United States
K25 CA172218 / CA / NCI NIH HHS / United States
S10 RR025439 / RR / NCRR NIH HHS / United States
P30 CA086862 / CA / NCI NIH HHS / United States
P50 CA097274 / CA / NCI NIH HHS / United States
P50 CA174521 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065